PL3041837T3 - Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny - Google Patents
Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynnyInfo
- Publication number
- PL3041837T3 PL3041837T3 PL14722366T PL14722366T PL3041837T3 PL 3041837 T3 PL3041837 T3 PL 3041837T3 PL 14722366 T PL14722366 T PL 14722366T PL 14722366 T PL14722366 T PL 14722366T PL 3041837 T3 PL3041837 T3 PL 3041837T3
- Authority
- PL
- Poland
- Prior art keywords
- crystal
- pharmaceutical composition
- active ingredient
- composition containing
- habit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013185313A JP5680161B1 (ja) | 2013-09-06 | 2013-09-06 | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| PCT/JP2014/060993 WO2015033612A1 (en) | 2013-09-06 | 2014-04-11 | Crystal having specific crystal habit and pharmaceutical composition containing the crystal as active ingredient |
| EP14722366.3A EP3041837B1 (en) | 2013-09-06 | 2014-04-11 | Crystal having specific crystal habit and pharmaceutical composition containing the crystal as active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3041837T3 true PL3041837T3 (pl) | 2022-06-06 |
Family
ID=50680085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14722366T PL3041837T3 (pl) | 2013-09-06 | 2014-04-11 | Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9527836B2 (pl) |
| EP (1) | EP3041837B1 (pl) |
| JP (1) | JP5680161B1 (pl) |
| KR (1) | KR20160053915A (pl) |
| CN (1) | CN105518002A (pl) |
| PL (1) | PL3041837T3 (pl) |
| WO (1) | WO2015033612A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5951864B1 (ja) * | 2015-06-05 | 2016-07-13 | 株式会社ポーラファルマ | 抗ジアルジア剤 |
| JP2017101009A (ja) * | 2015-12-04 | 2017-06-08 | 株式会社ポーラファルマ | 抗アカントアメーバ剤及びその製造法 |
| JP6085706B1 (ja) * | 2016-03-31 | 2017-02-22 | 株式会社ポーラファルマ | 抗トリトリコモナス剤 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60218387A (ja) | 1984-04-14 | 1985-11-01 | Nippon Nohyaku Co Ltd | ケテンｓ，ｓ−アセタ−ル類 |
| JP3081766B2 (ja) | 1994-05-06 | 2000-08-28 | 東興薬品工業株式会社 | 角質貯留型抗真菌外用組成物 |
| WO1997002821A2 (en) * | 1995-07-08 | 1997-01-30 | Nihon Nohyaku Co., Ltd. | Antifungal agent, compound therefor, process for producing the same |
| JP3278738B2 (ja) * | 1995-07-08 | 2002-04-30 | 日本農薬株式会社 | 抗真菌剤 |
| JP2003519698A (ja) | 2000-01-07 | 2003-06-24 | トランスフォーム ファーマスーティカルズ，インコーポレイテッド | 多様な固体形態のハイスループットでの形成、同定および分析 |
| JP2002114680A (ja) | 2000-07-31 | 2002-04-16 | Nippon Nohyaku Co Ltd | 抗真菌剤 |
| WO2007047253A2 (en) * | 2005-10-11 | 2007-04-26 | Eastman Chemical Company | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| EP2005958B1 (en) | 2006-03-08 | 2013-04-17 | Nihon Nohyaku Co., Ltd. | External pharmaceutical composition |
| JP5184342B2 (ja) | 2006-03-08 | 2013-04-17 | 日本農薬株式会社 | 外用の医薬組成物 |
| CA2645058C (en) | 2006-03-08 | 2013-07-30 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| US8492421B2 (en) | 2007-08-27 | 2013-07-23 | Nihon Nohyaku Co., Ltd. | Agent for fungal dermatitis |
| CN101808639B (zh) | 2007-09-05 | 2012-12-05 | 宝丽制药股份有限公司 | 抗真菌医药组合物 |
| US20100173965A1 (en) | 2007-09-05 | 2010-07-08 | Pola Pharma Inc. | Antifungal composition |
| JP5529539B2 (ja) | 2007-09-05 | 2014-06-25 | 株式会社ポーラファルマ | 医薬組成物 |
| JP5654497B2 (ja) | 2009-02-13 | 2015-01-14 | トピカ ファーマシューティカルズ，インコーポレイテッド | 抗真菌製剤 |
| US9050271B2 (en) | 2009-04-09 | 2015-06-09 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| US10130610B2 (en) | 2009-04-09 | 2018-11-20 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| JP5635075B2 (ja) | 2009-08-25 | 2014-12-03 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
| US8962669B2 (en) | 2010-06-11 | 2015-02-24 | Pola Pharma Inc. | Antimycotic pharmaceutical composition |
| CN103012385B (zh) * | 2012-02-17 | 2015-07-08 | 山东威智医药工业有限公司 | 卢立康唑的晶型及其制备方法 |
| CN104619704B (zh) * | 2012-09-14 | 2017-12-05 | 宝丽制药股份有限公司 | 表面自由能用于分化评价晶体的用途，基于表面自由能作为指标评价的晶体，以及通过包含所述晶体制备的药物组合物 |
| IN2015DN02376A (pl) * | 2012-09-14 | 2015-09-04 | Pola Pharma Inc | |
| EP2895164A1 (en) | 2012-09-14 | 2015-07-22 | Pola Pharma Inc. | Pharmaceutical composition containing luliconazole |
| JP5460797B1 (ja) | 2012-09-14 | 2014-04-02 | 株式会社ポーラファルマ | アミド誘導体及び安定性指標としてのその使用 |
| RU2622644C2 (ru) * | 2012-09-14 | 2017-06-19 | Пола Фарма Инк. | Кристаллическое вещество и содержащий его фармацевтический препарат |
| JP6254597B2 (ja) | 2013-01-28 | 2017-12-27 | 株式会社ポーラファルマ | カンジダ等の病原微生物による疾患用の医薬組成物 |
| WO2014115487A1 (en) | 2013-01-28 | 2014-07-31 | Pola Pharma Inc. | Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus |
| JP5589110B1 (ja) | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
| WO2014185542A1 (en) | 2013-05-17 | 2014-11-20 | Pola Pharma Inc. | Pharmaceutical composition for treating vaginitis or pneumonia |
-
2013
- 2013-09-06 JP JP2013185313A patent/JP5680161B1/ja active Active
-
2014
- 2014-04-11 WO PCT/JP2014/060993 patent/WO2015033612A1/en active Application Filing
- 2014-04-11 CN CN201480048566.XA patent/CN105518002A/zh active Pending
- 2014-04-11 EP EP14722366.3A patent/EP3041837B1/en active Active
- 2014-04-11 US US14/419,864 patent/US9527836B2/en active Active
- 2014-04-11 PL PL14722366T patent/PL3041837T3/pl unknown
- 2014-04-11 KR KR1020167005103A patent/KR20160053915A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US9527836B2 (en) | 2016-12-27 |
| JP2015051945A (ja) | 2015-03-19 |
| EP3041837A1 (en) | 2016-07-13 |
| US20160168136A1 (en) | 2016-06-16 |
| CN105518002A (zh) | 2016-04-20 |
| WO2015033612A1 (en) | 2015-03-12 |
| JP5680161B1 (ja) | 2015-03-04 |
| EP3041837B1 (en) | 2021-10-13 |
| KR20160053915A (ko) | 2016-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL244206A0 (en) | A pharmaceutical preparation containing a pyrimidine compound as an active ingredient | |
| RU2016118771A3 (en) | Co-crystals and pharmaceutical compositions comprising the same | |
| IL240290A0 (en) | History of pyridazinone-amide and pharmaceutical preparations containing them | |
| EP3043824A4 (en) | Modified therapeutic agents and compositions thereof | |
| IL263978B (en) | Amorphous latrovir and solid pharmaceutical preparations containing it and its uses | |
| PT3043773T (pt) | Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal | |
| EP3024824A4 (en) | THERAPEUTICALLY ACTIVE COMPOUNDS AND USE THEREOF | |
| EP2978420A4 (en) | STABLE NANOCOMPOSITION COMPRISING PACLITAXEL, PROCESS FOR ITS PREPARATION, USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| EP3087987A4 (en) | Pharmaceutical composition containing palonosetron | |
| HK1211021A1 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions 2--6--9--9h- | |
| EP2976091C0 (de) | Antioxidativ wirksame zusammensetzung und deren verwendung | |
| PT2988733T (pt) | Composição farmacêutica contendo macitentano cristalino | |
| EP2995308A4 (en) | ANTI-HYPOXIC PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| EP2987786A4 (en) | AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE | |
| IL240875B (en) | Heterocyclic compounds and pharmaceutical preparations containing them | |
| HK1219691A1 (zh) | 醫藥組成物及其用途 | |
| EP2989093A4 (en) | Novel triazole derivatives or salts thereof and pharmaceutical composition therefor | |
| IL244693A0 (en) | History of piperazine and their use as drugs | |
| EP2978421A4 (en) | STABLE NANOCOMPOSITION COMPRISING DOCATEXEL, PROCESS FOR PREPARATION THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| EP3078671A4 (en) | Gemcitabine derivative, composition containing the derivative and pharmaceutical use of the derivative | |
| PL3041837T3 (pl) | Kryształ o specyficznym pokroju kryształu i kompozycja farmaceutyczna zawierająca ten kryształ jako składnik czynny | |
| IL240292A0 (en) | History of quinazoline and pharmaceutical preparations containing them | |
| EP3087979A4 (en) | Sustained-release pharmaceutical composition containing acebrophylline and hydrophobic sustained-release agent | |
| GB201307082D0 (en) | Pharmaceutical composition comprising 15-HETrE and methods of using the same | |
| HUP1300496A2 (hu) | Stabil kombinációs gyógyszerkészítmény |